home / stock / afib / afib news

AFIB News and Press, Acutus Medical Inc. From 05/15/23

Stock Information
Company Name: Acutus Medical Inc.
Stock Symbol: AFIB
Market: NASDAQ
Website: acutusmedical.com
Menu
AFIB AFIB Quote AFIB Short AFIB News AFIB Articles AFIB Message Board
Get AFIB Alerts

News, Short Squeeze, Breakout and More Instantly...
AFIB - Acutus Medical to Showcase Innovative Cardiac Mapping and Ablation Technologies at HRS 2023

CARLSBAD, Calif., May 15, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, is pleased to announce its participation in the upcoming Heart Rhythm Socie...
AFIB - Acutus Medical, Inc. (AFIB) Q1 2023 Earnings Call Transcript

2023-05-11 23:38:06 ET Acutus Medical, Inc. (AFIB) Q1 2023 Earnings Conference Call May 11, 2023 16:30 ET Company Participants Caroline Corner - Investor Relations David Roman - President & Chief Executive Officer Takeo Mukai - Vice President of Finance &...

AFIB - Acutus Medical GAAP EPS of -$0.57 beats by $0.12, revenue of $4.2M beats by $0.3M

2023-05-11 16:11:05 ET Acutus Medical press release ( NASDAQ: AFIB ): Q1 GAAP EPS of -$0.57 beats by $0.12 . Revenue of $4.2M (+14.1% Y/Y) beats by $0.3M . 2023 Outlook The company expects full year 2023 revenue to be in a range from $19.0-$21.0 million vs ...

AFIB - Acutus Medical Reports First Quarter 2023 Financial Results

CARLSBAD, Calif., May 11, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today reported results for the first quarter...
AFIB - Acutus Medical to Announce First Quarter 2023 Financial Results

CARLSBAD, Calif., April 28, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, announced today that it will release its first quarter 2023 financial res...

AFIB - Acutus Medical gives prelim Q1 reports

2023-04-20 10:42:53 ET Arrhythmia management company, Acutus Medical ( NASDAQ: AFIB ) expects Q1 2023 revenue in the range of $4.1M-$4.2M vs. $3.7M in Q1 2022. ( consensus $3.87M ) Year-over-year growth was driven by higher AcQMap disposable revenue in marke...

AFIB - Acutus Medical Announces Preliminary Unaudited First Quarter 2023 Results

CARLSBAD, Calif., April 20, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today announced preliminary unaudited resu...
AFIB - RECOVER AF Study Reports 91% of First Redo Patients Achieved Freedom from AF at One Year After AcQMap-guided Ablation Therapy

CARLSBAD, Calif., April 20, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today announced results from the RECOVER AF study. The study, published o...

AFIB - Acutus Medical, Inc. (AFIB) Q4 2022 Earnings Call Transcript

2023-03-16 21:12:04 ET Start Time: 16:30 End Time: 17:14 Acutus Medical, Inc. (AFIB) Q4 2022 Earnings Conference Call March 16, 2023, 16:30 PM ET Company Participants David Roman - President and CEO Takeo Mukai - VP, Finance & Accounting, Interim CFO ...

AFIB - Acutus Medical GAAP EPS of $0.41 beats by $1.12, revenue of $5M beats by $0.45M

2023-03-16 16:03:30 ET Acutus Medical press release ( NASDAQ: AFIB ): Q4 GAAP EPS of $0.41 beats by $1.12 . Revenue of $5M (+14.7% Y/Y) beats by $0.45M . Non-GAAP operating expenses were $13.9 million for the fourth quarter of 2022 compared with $21.4 million i...
Previous 10 Next 10